Availability, accessibility, usage and regulatory environment for novel and emerging tobacco, nicotine or related products

by Ellen Nolte, Annalijn Conklin, Laura Brereton, Claire Celia, Simo Goshev, Flavia Tsang, Clemence Pasmans

Download eBook for Free

FormatFile SizeNotes
PDF file 1.1 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

The European Commission Health and Consumer Directorate-General (DG SANCO) commissioned RAND Europe, by way of the Executive Agency for Health and Consumers, in the framework of the Health Programme (No SC 2010 6306), to examine the availability, accessibility, usage and regulatory environment for novel and emerging tobacco, nicotine and related products in European Union Member States. Drawing on a range of methodological approaches involving systematic evidence review, key informant interviews with representatives from industry, including retailers, and a survey of stakeholders at national governmental and non-governmental agencies, this report will serve to inform further a possible revision of the Tobacco Products Directive 2001/37/EC. The report also provides an up-to-date overview of the evidence and basis for current tobacco and related products regulation that may be of interest to a wider audience interested in tobacco control policies.

Table of Contents

  • Chapter One

    Introduction

  • Chapter Two

    Our approach

  • Chapter Three

    Availability, accessibility and use of novel and emerging tobacco, nicotine or related products: evidence review

  • Chapter Four

    Marketing of novel and emerging tobacco, nicotine or related products: key informant interviews

  • Chapter Five

    Availability, accessibility and use of novel and emerging tobacco, nicotine or related products: stakeholder survey

  • Chapter Six

    Conclusions

  • Appendix A

    Evidence review stage I

  • Appendix B

    Key informant interview topic guide

  • Appendix C

    Abbreviated survey addressed to medicines agencies

  • Appendix D

    Regulation of novel tobacco and nicotine products by type of regulation

Research conducted by

The research described in this report was prepared for the Executive Agency for Health and Consumers (EAHC) and conducted by RAND Europe.

This report is part of the RAND Corporation Research report series. RAND reports present research findings and objective analysis that address the challenges facing the public and private sectors. All RAND reports undergo rigorous peer review to ensure high standards for research quality and objectivity.

This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.